Application Sponsors
ANDA 209013 | UPSHER SMITH LABS | |
Marketing Status
Prescription | 001 |
Prescription | 002 |
Prescription | 003 |
Prescription | 004 |
Application Products
001 | TABLET;ORAL | EQ 1MG BASE | 0 | DOXAZOSIN MESYLATE | DOXAZOSIN MESYLATE |
002 | TABLET;ORAL | EQ 2MG BASE | 0 | DOXAZOSIN MESYLATE | DOXAZOSIN MESYLATE |
003 | TABLET;ORAL | EQ 4MG BASE | 0 | DOXAZOSIN MESYLATE | DOXAZOSIN MESYLATE |
004 | TABLET;ORAL | EQ 8MG BASE | 0 | DOXAZOSIN MESYLATE | DOXAZOSIN MESYLATE |
FDA Submissions
UNKNOWN; | ORIG | 1 | AP | 2018-04-17 | STANDARD |
Submissions Property Types
TE Codes
001 | Prescription | AB |
002 | Prescription | AB |
003 | Prescription | AB |
004 | Prescription | AB |
CDER Filings
UPSHER SMITH LABS
cder:Array
(
[0] => Array
(
[ApplNo] => 209013
[companyName] => UPSHER SMITH LABS
[docInserts] => ["",""]
[products] => [{"drugName":"DOXAZOSIN MESYLATE","activeIngredients":"DOXAZOSIN MESYLATE","strength":"EQ 1MG BASE","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"DOXAZOSIN MESYLATE","activeIngredients":"DOXAZOSIN MESYLATE","strength":"EQ 2MG BASE","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"DOXAZOSIN MESYLATE","activeIngredients":"DOXAZOSIN MESYLATE","strength":"EQ 4MG BASE","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"DOXAZOSIN MESYLATE","activeIngredients":"DOXAZOSIN MESYLATE","strength":"EQ 8MG BASE","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"04\/17\/2018","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
[supplements] =>
[actionDate] => 2018-04-17
)
)